Grown Rogue International Inc
CNSX:GRIN
Operating Margin
Grown Rogue International Inc
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | Company | Market Cap |
Operating Margin |
||
---|---|---|---|---|---|
CA |
G
|
Grown Rogue International Inc
CNSX:GRIN
|
125m CAD |
-1%
|
|
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
757.1B USD |
40%
|
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
3%
|
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
406.8B USD |
26%
|
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
2T DKK |
45%
|
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
207.8B CHF |
33%
|
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
179.9B CHF |
33%
|
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
165.5B GBP |
24%
|
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
211.3B USD |
34%
|
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
183.8B USD |
11%
|
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
144.2B USD |
27%
|
Grown Rogue International Inc
Glance View
Grown Rogue International, Inc. operates as a seed to experience cannabis brand. The company is headquartered in Toronto, Ontario. The company went IPO on 2016-11-18. The Company’s geographical segments include the United States and Canada. The firm is a vertically integrated cannabis brand that produces and distributes cannabis products. The firm's products include sungrown and indoor flowers, along with nitro-sealed indoor, and sungrown pre-rolls and jars.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Grown Rogue International Inc's most recent financial statements, the company has Operating Margin of -1.2%.